Jeffrey K. Tong
Chairman of the BoardDr. Jeffrey K. Tong, also known as Jeff, Ph.D., serves as a Director at Artbio Inc. He is Director of Trace Neuroscience, Inc. He is Partner of Third Rock Ventures, LLC from 2025. Dr. Tong joined the Third Rock Ventures, LLC in 2016. Dr. Tong focuses on drug discovery and development. Dr. Tong was Partner & Board Member of Third Rock Ventures, LLC from December 2018 to 2025. Dr. Tong was Venture Partner of Third Rock Ventures, LLC until December 2018. Dr. Tong was Entrepreneur-in-Residence of Third Rock Ventures, LLC. Dr. Tong is Chairman of the Board of Ambys Medicines, Inc. Dr. Tong is Director of Asher Biotherapeutics, Inc. Dr. Tong is Chairman of the Board of Septerna, Inc. from November 2021. Dr. Tong is Director of Marea Therapeutics, Inc. Dr. Tong is Director of Candid Therapeutics, Inc. He serves as board at Trace Neuroscience. Dr. Tong was Vice President of Corporate & Product Development of Infinity Pharmaceuticals, Inc. Dr. Tong was CEO, President & Director of Nora Therapeutics, Inc. Dr. Tong was Chairman of Delinia, Inc. Dr. Tong joined the Delinia, Inc. on September 14, 2016. Dr. Tong was Independent Director of Nurix Therapeutics, Inc. from February 2018 to May 05, 2022. Dr. Tong was employed at Nurix Therapeutics, Inc. until May 05, 2022. Dr. Tong was Independent Director of Maze Therapeutics, Inc. from November 2018 to February 2025. Dr. Tong was Director of Maze Therapeutics, Inc. from November 2018. Dr. Tong was employed at Maze Therapeutics, Inc. until February 2025. Dr. Tong was Director of Terremoto Biosciences, Inc. Dr. Tong was Independent Director of Rapport Therapeutics, Inc. from December 2022 to November 2024. Dr. Tong was employed at Rapport Therapeutics, Inc. until November 2024. Dr. Tong has B.A. in Biomedical Sciences from Harvard University, Ph.D. in Chemistry from Harvard Graduate School Of Arts And Sciences, M.A. in Chemistry from Harvard Graduate School Of Arts And Sciences, Master's in Medical Science from Harvard Medical School.
Positions
- Company NameSepterna, Inc.Stock CodeSEPNPositionChairman of the BoardColleagues
- JTJeffrey T. FinerCo-Founder, CEO & Director
- EPElizabeth P. BhattPresident & COO
- GMGilbert M. LabrucherieChief Financial Officer
- RJRobert J. LefkowitzCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
- ACArthur ChristopoulosCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
- PSPatrick SextonCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
